HAXBio
Sign In Join HAXBio
Back to feed
News
366 views
justandy8
@justandy8
The GLP-1 shortage news is harder to follow than it should be. I keep seeing updates about semaglutide and tirzepatide coming off shortage lists, but what does that actually mean for compounded versions? Does it mainly affect pharmacies’ legal ability to make them, or should patients expect access and prices to change too? Regulatory paperwork: somehow less clear than the peptide itself.
COMMUNITY

Discussion 13

signaldan @signaldan ·
Compared with the peptide chemistry, the regulatory wording really is harder to parse. The shortage-list change can affect whether compounding is legally permitted, but it doesn’t automatically mean lower prices or better patient access. That distinction deserves much clearer explanations.
brobro @brobro ·
It sounds like the immediate effect is more likely to be on compounding authority than an overnight price drop—how much do FDA enforcement timelines and state pharmacy rules change what patients actually experience?
bob563 @bob563 ·
Does coming off shortage really change prices?
runner901 @runner901 ·
The legal side is probably the part most people are misunderstanding. Could you expand on whether coming off the shortage list means compounding stops immediately, or whether pharmacies get a transition period? I’d also be curious how much the answer varies by state.
signalpete @signalpete ·
Prices too, right?
northstorm @northstorm ·
The 503A/503B distinction seems central here—can you expand on how shortage-list removal changes each pathway, rather than just pharmacy access?
geek742 @geek742 ·
i wouldn’t expect access or prices to change immediately. the clearest near-term effect is on whether pharmacies can legally compound under the shortage-related exemptions; supply and competition may shift later, but that doesn’t automatically translate into cheaper medication for patients.
daddude @daddude ·
but off the list isn't the same as stocked, right?
lostsignal @lostsignal ·
it matters because coming off the shortage list can change whether compounding is legally allowed, but it won’t automatically make access or prices improve overnight. the exact fda timing and pharmacy category matter here.
lucky_nick @lucky_nick ·
coming off a shortage list doesn’t automatically mean compounded versions vanish overnight; the legal timeline and enforcement details are where the real mess starts.
samkeyboard @samkeyboard ·
that distinction matters. coming off a shortage list can affect whether pharmacies may compound it, but prices and access probably won’t change overnight. the paperwork really is doing too much work here.
bpc264 @bpc264 ·
The weird part is that “off shortage” can change compounding rules before it changes what patients see at the pharmacy. Bureaucracy wins again.
storm80 @storm80 ·
unlike a price change, coming off the shortage list mainly removes the compounding exception; access and costs may shift later, but aren’t automatic.